Searching journal content for articles similar to Máximo et al. 23 (12): X2.

Displaying results 1-10 of 15
For checked items
  1. Research:
    • Rodrigo A Toledo,
    • Roxanne Hatakana,
    • Delmar M Lourenço, Jr,
    • Susan C Lindsey,
    • Cleber P Camacho,
    • Marcio Almeida,
    • José V Lima, Jr,
    • Tomoko Sekiya,
    • Elena Garralda,
    • Michel S Naslavsky,
    • Guilherme L Yamamoto,
    • Monize Lazar,
    • Osorio Meirelles,
    • Tiago J P Sobreira,
    • Maria Lucia Lebrao,
    • Yeda A O Duarte,
    • John Blangero,
    • Mayana Zatz,
    • Janete M Cerutti,
    • Rui M B Maciel,
    • and Sergio P A Toledo
    Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility Endocr Relat Cancer 22 (1) 65-76, doi:10.1530/ERC-14-0491 first published on 25 November 2014
    ...without MTC.5Division of Genetics, Genetic Bases of Thyroid Tumors Laboratory, Department of Morphology and Genetics, and 6Division of Endocrinology, Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Federal University of Sa˜o Paulo, Sa˜o Paulo, Sa˜o Paulo, Brazil 7Brazilian...
    OPEN ACCESS ARTICLE
  2. Review:
    • Kyoungjune Pak,
    • Seong-Jang Kim,
    • In Joo Kim,
    • Bo Hyun Kim,
    • Sang Soo Kim,
    • and Yun Kyung Jeon
    The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery Endocr Relat Cancer 20 (4) R203-R213, doi:10.1530/ERC-13-0088 first published on 30 May 2013
    .... As less FDG-avid thyroid cancers may lower the diagnostic accuracy of PET in preoperative assessment, an understanding of FDG avidity is important for the evaluation of thyroid cancer. FDG avidity has been shown to be associated with tumor size, lymph node metastasis, and glucose transporter expression...
  3. Review:
    • Valdemar Máximo,
    • Jorge Lima,
    • Hugo Prazeres,
    • Paula Soares,
    • and Manuel Sobrinho-Simões
    The biology and the genetics of Hürthle cell tumors of the thyroid Endocr Relat Cancer 19 (4) R131-R147, doi:10.1530/ERC-11-0354 first published on 18 April 2012
    ...initiation to metastization.Abstract The biology and the genetics of Hu¨rthle cell tumors are reviewed starting from the characterization and differential diagnosis of the numerous benign and malignant, neoplastic and nonneoplastic lesions of the thyroid in which Hu¨rthle cell transformation is frequently...
  4. Thematic Review:
    • Susan J Hsiao and
    • Yuri E Nikiforov
    Molecular approaches to thyroid cancer diagnosis Endocr Relat Cancer 21 (5) T301-T313, doi:10.1530/ERC-14-0166 first published on 14 May 2014
    ...categories: atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), follicular or oncocytic (Hu¨rthle cell) neoplasm/suspicious for aunderlying thyroid cancer predisposition remain to be identified within candidate genes in these regions. Thyroid tumor development...
  5. Review:
    • Rengyun Liu and
    • Mingzhao Xing
    TERT promoter mutations in thyroid cancer Endocr Relat Cancer 23 (3) R143-R155, doi:10.1530/ERC-15-0533 first published on 5 January 2016
    ...on the histological nature of the benign tumor (Wang et al. 2014b). Thus, the prevalence of TERT promoter mutations in the large number of true benign thyroid neoplasms is 0%. TERT promoter mutation is a rare genetic event in PTMC as demonstrated in the study of de Biase et al. (2015) which examined the TERT promoter...
  6. Research:
    • Soazig Le Pennec,
    • Tomasz Konopka,
    • David Gacquer,
    • Danai Fimereli,
    • Maxime Tarabichi,
    • Gil Tomás,
    • Frédérique Savagner,
    • Myriam Decaussin-Petrucci,
    • Christophe Trésallet,
    • Guy Andry,
    • Denis Larsimont,
    • Vincent Detours,
    • and Carine Maenhaut
    Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases Endocr Relat Cancer 22 (2) 205-216, doi:10.1530/ERC-14-0351 first published on 17 February 2015
    ...in thyroid cancer. Firstly, the primary PTC, the two LN metastases, and the PLM were composed of several cellular subclones in this patient. Despite the presence of these subclones, the two areas of the primary tumor and the two areas of the LN metastasis 2 presented similar genetic profiles. In contrast...
  7. Review:
    • Lucas Leite Cunha,
    • Marjory Alana Marcello,
    • and Laura Sterian Ward
    The role of the inflammatory microenvironment in thyroid carcinogenesis Endocr Relat Cancer 21 (3) R85-R103, doi:10.1530/ERC-13-0431 first published on 3 December 2013
    ...microenvironment in thyroid to L S Ward Email [email protected] tumor progression. The inflammatory microenvironment may help to characterize Key Words " thyroid carcinomas " inflammatory microenvironment " tumor-infiltrating lymphocytes " tumor-associated macrophages a mixture of lymphocytes y...
  8. Review:
    • Cosimo Durante,
    • Giuseppe Costante,
    • and Sebastiano Filetti
    Differentiated thyroid carcinoma: defining new paradigms for postoperative management Endocr Relat Cancer 20 (4) R141-R154, doi:10.1530/ERC-13-0066 first published on 9 April 2013
    ...-Department of Health Sciences, University of Catanzaro ‘Magna Graecia’, 88100 Catanzaro, Italy Abstract The demography of differentiated thyroid cancers (DTCs) has changed considerably since the 1990s, when the vast majority of these tumors were clinically evident at the time of diagnosis, and many were associated...
  9. Regular papers:
    • Roberto Bellelli,
    • Maria Domenica Castellone,
    • Ginesa Garcia-Rostan,
    • Clara Ugolini,
    • Carmelo Nucera,
    • Peter M Sadow,
    • Tito Claudio Nappi,
    • Paolo Salerno,
    • Maria Carmela Cantisani,
    • Fulvio Basolo,
    • Tomas Alvarez Gago,
    • Giuliana Salvatore,
    • and Massimo Santoro
    FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma Endocr Relat Cancer 19 (5) 695-710, doi:10.1530/ERC-12-0031 first published on 23 August 2012
    ...cancer. Anaplastic thyroid carcinoma (ATC) is a rare tumor (Kondo et al. 2006, Smallridge et al. 2009). Endocrine-Related Cancer (2012) 19 695–710distant sites. Multimodal therapy, including surgery,that accounts for 2–5% of all thyroid cancers. ATC ranks among the most lethal solid malignancies...
  10. Review:
    • Garcilaso Riesco-Eizaguirre and
    • Pilar Santisteban
    New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy Endocr Relat Cancer 14 (4) 957-977, doi:10.1677/ERC-07-0085
    ...the different mutations. Studies in vitro and in vivo, including genomic profiling and genetically engineered mouse models, have clearly shown that each oncoprotein exerts its own oncogenic drive, conferring a distinct biological behaviour on thyroid tumours. In this review, we attempt to summarise the most...
For checked items

Search Results

Next 5 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most